Jeffrey T. Mihalic

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bifunctional compounds for degrading BTK via ubiquitin proteosome p...
- Patent number 11,866,442
- Issue date Jan 9, 2024
- NURIX THERAPEUTICS, INC.
- Daniel W. Robbins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional compounds for degrading BTK via ubiquitin proteosome p...
- Patent number 11,479,556
- Issue date Oct 25, 2022
- NURIX THERAPEUTICS, INC.
- Daniel W. Robbins
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl-substituted triazoles as APJ receptor agonists
- Patent number 11,046,680
- Issue date Jun 29, 2021
- Amgen Inc.
- Ning Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole furan compounds as agonists of the APJ receptor
- Patent number 10,736,883
- Issue date Aug 11, 2020
- Amgen Inc.
- Matthew Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bromotriazole intermediates
- Patent number 10,344,016
- Issue date Jul 9, 2019
- Amgen Inc.
- Paul John Dransfield
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole agonists of the APJ receptor
- Patent number 10,221,162
- Issue date Mar 5, 2019
- Amgen Inc.
- Ning Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating heart failure
- Patent number 10,058,550
- Issue date Aug 28, 2018
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole agonists of the APJ receptor
- Patent number 9,868,721
- Issue date Jan 16, 2018
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Intermediates for preparing triazole agonists of the APJ receptor
- Patent number 9,845,310
- Issue date Dec 19, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing triazole agonists of the APJ receptor
- Patent number 9,751,864
- Issue date Sep 5, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole agonists of the APJ receptor
- Patent number 9,745,286
- Issue date Aug 29, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole agonists of the APJ receptor
- Patent number 9,656,997
- Issue date May 23, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Intermediates for preparing triazole agonists of the APJ receptor
- Patent number 9,656,998
- Issue date May 23, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazole agonists of the APJ receptor
- Patent number 9,573,936
- Issue date Feb 21, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
- Patent number 9,376,425
- Issue date Jun 28, 2016
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...
- Patent number 8,980,903
- Issue date Mar 17, 2015
- Amgen Inc.
- Richard V. Connors
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...
- Patent number 8,841,312
- Issue date Sep 23, 2014
- Amgen Inc.
- Richard V. Connors
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions and methods for prevention and treatment of...
- Patent number 7,939,538
- Issue date May 10, 2011
- Amgen Inc.
- Zice Fu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl nitrile compounds and compositions and their uses in treating...
- Patent number 7,799,795
- Issue date Sep 21, 2010
- Amgen Inc.
- Philippe Bergeron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzofused heterocycles
- Patent number 7,572,783
- Issue date Aug 11, 2009
- Amgen Inc.
- Xi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]p...
- Patent number 7,375,102
- Issue date May 20, 2008
- Amgen SF, LLC
- Zice Fu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolo-related compounds, compositions and methods for their use
- Patent number 7,271,271
- Issue date Sep 18, 2007
- Amgen SF, LLC
- Zice Fu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds
- Patent number 7,253,179
- Issue date Aug 7, 2007
- Amgen Inc.
- Xi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibacterial agents
- Patent number 7,148,259
- Issue date Dec 12, 2006
- Amgen Inc.
- Leping Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused heterocyclic compounds
- Patent number 7,125,885
- Issue date Oct 24, 2006
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibacterial agents
- Patent number 7,053,234
- Issue date May 30, 2006
- Amgen Inc.
- Leping Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine derivatives
- Patent number 7,045,527
- Issue date May 16, 2006
- Amgen Inc.
- Xiaoqi Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused heterocyclic compounds
- Patent number 6,858,619
- Issue date Feb 22, 2005
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING...
- Publication number 20240279202
- Publication date Aug 22, 2024
- Nurix Therapeutics, Inc.
- Joel MCINTOSH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...
- Publication number 20240124475
- Publication date Apr 18, 2024
- Nurix Therapeutics, Inc.
- Daniel W. ROBBINS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS...
- Publication number 20230158151
- Publication date May 25, 2023
- Nurix Therapeutics, Inc.
- Eric Wegryzniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...
- Publication number 20230029378
- Publication date Jan 26, 2023
- Nurix Therapeutics, Inc.
- Daniel W. ROBBINS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR GRADING BTK VIA UBIQUITIN PROTEOSOME PAT...
- Publication number 20230024442
- Publication date Jan 26, 2023
- NURIX THERAPEUTICS, INC.
- Daniel W. ROBBINS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF CBL-B AND METHODS OF USE THEREOF
- Publication number 20220324835
- Publication date Oct 13, 2022
- Nurix Therapeutics, Inc.
- Paul A. BARSANTI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...
- Publication number 20220143195
- Publication date May 12, 2022
- Nurix Therapeutics, Inc.
- Diasuke KATO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
- Publication number 20190275008
- Publication date Sep 12, 2019
- Amgen Inc.
- Matthew BROWN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BROMOTRIAZOLE INTERMEDIATES
- Publication number 20190100510
- Publication date Apr 4, 2019
- Amgen Inc.
- Paul John Dransfield
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20180319773
- Publication date Nov 8, 2018
- Amgen Inc.
- Ning Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING HEART FAILURE
- Publication number 20170281625
- Publication date Oct 5, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20170042872
- Publication date Feb 16, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20170042897
- Publication date Feb 16, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20170042871
- Publication date Feb 16, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20170044131
- Publication date Feb 16, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20170037026
- Publication date Feb 9, 2017
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20170035744
- Publication date Feb 9, 2017
- Amgen Inc.
- Ning CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
- Publication number 20160340336
- Publication date Nov 24, 2016
- Amgen Inc.
- Ning Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INH...
- Publication number 20140350244
- Publication date Nov 27, 2014
- Richard V. Connors
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20140235629
- Publication date Aug 21, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20110319378
- Publication date Dec 29, 2011
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inh...
- Publication number 20110142796
- Publication date Jun 16, 2011
- Amgen Inc.
- Richard V. Connors
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jeffrey T. Mihalic

Person

Patents Grantslast 30 patents

Bifunctional compounds for degrading BTK via ubiquitin proteosome p...

Bifunctional compounds for degrading BTK via ubiquitin proteosome p...

Heteroaryl-substituted triazoles as APJ receptor agonists

Triazole furan compounds as agonists of the APJ receptor

Bromotriazole intermediates

Triazole agonists of the APJ receptor

Methods of treating heart failure

Triazole agonists of the APJ receptor

Intermediates for preparing triazole agonists of the APJ receptor

Methods for preparing triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Triazole agonists of the APJ receptor

Intermediates for preparing triazole agonists of the APJ receptor

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Triazole agonists of the APJ receptor

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...

Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...

Compounds, compositions and methods for prevention and treatment of...

Aryl nitrile compounds and compositions and their uses in treating...

Substituted benzofused heterocycles

Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]p...

Imidazolo-related compounds, compositions and methods for their use

Fused heterocyclic compounds

Antibacterial agents

Fused heterocyclic compounds

Antibacterial agents

Piperidine derivatives

Fused heterocyclic compounds

Patents Applicationslast 30 patents

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING...

BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...

COMPOUNDS FOR INHIBITING OR DEGRADING TARGET PROTEINS, COMPOSITIONS...

BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...

BIFUNCTIONAL COMPOUNDS FOR GRADING BTK VIA UBIQUITIN PROTEOSOME PAT...

INHIBITORS OF CBL-B AND METHODS OF USE THEREOF

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME P...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR

BROMOTRIAZOLE INTERMEDIATES

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

METHODS OF TREATING HEART FAILURE

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

TRIAZOLE AGONISTS OF THE APJ RECEPTOR

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INH...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inh...